Serological method using recombinant S2 protein to differentiate Equine Infectious Anemia Virus (EIAV)-infected and EIAV-vaccinated horses

Clinical and Diagnostic Laboratory Immunology

Volumn 11, Issue 6, 2004, Pages 1120-1129

  Jin, Sha ^a   Issel, Charles J ^b   Montelaro, Ronald C ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN S II; UNCLASSIFIED DRUG; VIRUS ANTIGEN; VIRUS PROTEIN;

ANTIBODY DETECTION; ANTIGEN EXPRESSION; ANTIGEN PURIFICATION; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EQUINE INFECTIOUS ANEMIA VIRUS; GENE SEQUENCE; HORSE; IMMUNOREACTIVITY; NONHUMAN; PRIORITY JOURNAL; RETROVIRUS INFECTION; SEQUENCE ALIGNMENT; SERODIAGNOSIS; SEROLOGY; VACCINATION;

ANIMALS; ANTIBODIES, VIRAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; EQUINE INFECTIOUS ANEMIA; HORSES; INFECTIOUS ANEMIA VIRUS, EQUINE; PREDICTIVE VALUE OF TESTS; VIRAL PROTEINS; VIRAL VACCINES;

EID: 9144250356     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/CDLI.11.6.1120-1129.2004     Document Type: Article

References (33)

1. gag. J. Clin. Microbiol. 27:1167-1173.
2. Ball, J. M., K. E. Rushlow, C. J. Issel, and R. C. Montelaro. 1992. Detailed mapping of the antigenicity of the surface unit glycoprotein of equine infectious anemia virus by using synthetic peptide strategies. J. Virol. 66:732-742.
3. Birkelt, A. J., B. Yelamos, I. Rodriguez-Crespo, F. Gavilanes, and D. L. Peterson. 1997. Cloning expression, purification, and characterization of the major core protein (p26) from equine infectious anemia virus. Biochim. Biophys. Acta 1339:62-72.
4. Carroll, R., and D. Derse. 1993. Translation of equine infectious anemia virus bicistronic tat-rev mRNA requires leaky ribosome scanning of the tat CTG initiation codon. J. Virol. 67:1433-1440.
5. Coggins, L., and N. L. Norcross. 1970. Immunodiffusion reaction in equine infectious anemia. Cornell Vet. 60:330-335.
6. Cook, R. F., C. Leroux, S. J. Cook, S. L. Berger, D. L. Lichtenstein, N. N. Ghabrial, R. C. Montelaro, and C. J. Issel. 1998. Development and characterization of an in vivo pathogenic molecular clone of equine infectious anemia virus. J. Virol. 72:1383-1393.
7. Fuerst, T. R., E. G. Niles, F. W. Studier, and B. Moss. 1986. Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase. Proc. Natl. Acad. Sci. USA 83:8122-8126.
8. Hammond, S. A., S. J. Cook, L. D. Falo, Jr., C. J. Issel, and R. C. Montelaro. 1999. A particulate viral protein vaccine reduces viral load and delays progression to disease in immunized ponies challenged with equine infectious anemia virus. Virology 254:37-49.
9. Hammond, S. A., F. Li, B. M. McKeon, Sr., S. J. Cook, C. J. Issel, and R. C. Montelaro. 2000. Immune responses and viral replication in long-term inapparent carrier ponies inoculated with equine infectious anemia virus. J. Virol. 74:5968-5981.
10. Henderson, L. E., R. C. Sowder, G. W. Smythers, and S. Oroszlan. 1987. Chemical and immunological characterizations of equine infectious anemia virus gag-encoded proteins. J. Virol. 61:1116-1124.
11. Hussain, K. A., C. J. Issel, K. L. Schnorr, P. M. Rwambo, and R. C. Montelaro. 1987. Antigenic analysis of equine infectious anemia virus (EIAV) variants by using monoclonal antibodies: epitopes of glycoprotein gp90 of EIAV stimulate neutralizing antibodies. J. Virol. 61:2956-2961.
12. Hussain, K. A., C. J. Issel, K. L. Schnorr, P. M. Rwambo, M. West, and R. C. Montelaro. 1988. Antigenic mapping of the envelope proteins of equine infectious anemia virus: identification of a neutralization domain and a conserved region on glycoprotein 90. Arch. Virol. 98:213-224.
13. Issel, C. J., and W. V. Adams, Jr. 1982. Detection of equine infectious anemia virus in a horse with an equivocal agar gel immunodiffusion test reaction. J. Am. Vet. Med. Assoc. 180:276-278.
14. Issel, C. J., and L. Coggins. 1979. Equine infectious anemia: current knowledge. J. Am. Vet. Med. Assoc. 174:727-733.
15. Issel, C. J., and R. F. Cook. 1993. A review of techniques for the serologic diagnosis of equine infectious anemia. J. Vet. Diagn. Investig. 5:137-141.
16. Issel, C. J., D. W. Horohov, D. F. Lea, W. V. Adams, Jr., S. D. Hagius, J. M. McManus, A. C. Allison, and R. C. Montelaro. 1992. Efficacy of inactivated whole-virus and subunit vaccines in preventing infection and disease caused by equine infectious anemia virus. J. Virol. 66:3398-3408.
17. Knowles, D. P., Jr., and J. R. Gorham. 1993. Advances in the diagnosis of some parasitic diseases by monoclonal antibody-based enzyme-linked immunosorbent assays. Rev. Sci. Technol. 12:425-433.
18. Kong, X. G., H. Pang, T. Sugiura, H. Sentsui, T. Onodera, Y. Matsumoto, and H. Akashi. 1997. Application of equine infectious anemia virus core proteins produced in a baculovirus expression system to serological diagnosis. Microbiol. Immunol. 41:975-980.
19. Li, F., J. K. Craigo, L. Howe, J. D. Steckbeck, S. Cook, C. Issel, and R. C. Montelaro. 2003. A live attenuated equine infectious anemia virus proviral vaccine with a modified S2 gene provides protection from detectable infection by intravenous virulent virus challenge of experimentally inoculated horses. J. Virol. 77:7244-7253.
20. Li, F., C. Leroux, J. K. Craigo, S. J. Cook, C. J. Issel, and R. C. Montelaro. 2000. The S2 gene of equine infectious anemia virus is a highly conserved determinant of viral replication and virulence properties in experimentally infected ponies. J. Virol. 74:573-579.
21. Li, F., B. A. Puffer, and R. C. Montelaro. 1998. The S2 gene of equine infectious anemia virus is dispensable for viral replication in vitro. J. Virol. 72:8344-8348.
22. Mia, A. S., M. M. Tierney, and D. M. Krevcak. 1982. Detection of equine infectious anemia antibody by a rapid microenzyme linked immunosorbent assay (ELISA). Proc. Annu. Meet. Am. Assoc. Vet. Lab. Diagn. 25:159-166.
23. Montelaro, R. C., W. G. Robey, M. D. West, C. J. Issel, and P. J. Fischinger. 1988. Characterization of the serological cross-reactivity between glycoproteins of the human immunodeficiency virus and equine infectious anaemia virus. J. Gen. Virol. 69:1711-1717.
24. Montelaro, R. C., W. G. Robey, M. D. West, C. J. Issel, and P. J. Fischinger. 1993. Equine retroviruses, vol. 2. Plenum Press, New York, N.Y.
25. Raabe, M. L., C. J. Issel, S. J. Cook, R. F. Cook, B. Woodson, and R. C. Montelaro. 1998. Immunization with a recombinant envelope protein (rgp90) of EIAV produces a spectrum of vaccine efficacy ranging from lack of clinical disease to severe enhancement. Virology 245:151-162.
26. Raabe, M. L., C. J. Issel, and R. C. Montelaro. 1999. In vitro antibody-dependent enhancement assays are insensitive indicators of in vivo vaccine enhancement of equine infectious anemia virus. Virology 259:416-427.
27. Reischl, U. 1996. Application of molecular biology-based methods to the diagnosis of infectious diseases. Front. Biosci. 1:e72-e77.
28. Schiltz, R. L., D. S. Shih, S. Rasty, R. C. Montelaro, and K. E. Rushlow. 1992. Equine infectious anemia virus gene expression: characterization of the RNA splicing pattern and the protein products encoded by open reading frames S1 and S2. J. Virol. 66:3455-3465.
29. Sellon, D. C., F. J. Fuller, and T. C. McGuire. 1994. The immunopathogenesis of equine infectious anemia virus. Virus Res. 32:111-138.
30. Shane, B. S., C. J. Issel, and R. C. Montelaro. 1984. Enzyme-linked immunosorbent assay for detection of equine infectious anemia virus p26 antigen and antibody. J. Clin. Microbiol. 19:351-355.
31. Soutullo, A., V. Verwimp, M. Riveros, R. Pauli, and G. Tonarelli. 2001. Design and validation of an ELISA for equine infectious anemia (EIA) diagnosis using synthetic peptides. Vet. Microbiol. 79:111-121.
32. Suzuki, T., S. Ueda, and T. Samejima. 1982. Enzyme-linked immunosorbent assay for diagnosis of equine infectious anemia. Vet. Microbiol. 7:307-315.
33. Wang, S. Z., K. E. Rushlow, C. J. Issel, R. F. Cook, S. J. Cook, M. L. Raabe, Y. H. Chong, L. Costa, and R. C. Montelaro. 1994. Enhancement of EIAV replication and disease by immunization with a baculovirus-expressed recombinant envelope surface glycoprotein. Virology 199:247-251.